Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-007307
Filing Date
2015-08-14
Accepted
2015-08-13 19:20:36
Documents
14
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20150630.htm 10-Q 1727163
2 EX-10.1 rare-ex101_594.htm EX-10.1 70601
3 EX-10.2 rare-ex102_595.htm EX-10.2 11981
4 EX-31.1 rare-ex311_6.htm EX-31.1 14663
5 EX-31.2 rare-ex312_8.htm EX-31.2 14737
6 EX-32.1 rare-ex321_7.htm EX-32.1 10050
7 GRAPHIC g201508132200047883069.jpg GRAPHIC 54941
8 GRAPHIC g201508132159334843281.jpg GRAPHIC 21021
  Complete submission text file 0001564590-15-007307.txt   5606537

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT rare-20150630.xml EX-101.INS 1206447
10 XBRL TAXONOMY EXTENSION SCHEMA rare-20150630.xsd EX-101.SCH 34552
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20150630_cal.xml EX-101.CAL 34444
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20150630_def.xml EX-101.DEF 82579
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20150630_lab.xml EX-101.LAB 243412
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20150630_pre.xml EX-101.PRE 181575
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 151052139
SIC: 2834 Pharmaceutical Preparations